American College of Clinical Pharmacy
      Search      Cart
         

PSAP in JACCP





Session Overview

PSAP in JACCP features are developed from topic updates published in the Pharmacotherapy Self-Assessment Program (PSAP). Each feature is provided free to ACCP members in an issue of the Journal of the American College of Clinical Pharmacy and consists of two parts:

  1. A series of PDF pages with learning objectives, abbreviations list, baseline knowledge statements, additional readings, reference list, and Self-Assessment Questions. These pages are listed as PSAP in JACCP in the journal’s table of contents.
  2. A series of interactive webpages, each introduced by a sample patient case or practice scenario. These webpages are accessed from a hyperlink included in the journal’s PDF pages.

PSAP in JACCP features are available for continuing pharmacy education (CPE) credit. See the following for information on CPE and how to purchase the required posttest for credit.

 

Faculty Information

This feature was developed from the Hepatitis C Virus Infection chapter published in PSAP 2018 Book 1 (Infectious Diseases).

Author information: Paulina Deming, Pharm.D., PhC, is an associate professor in the Department of Pharmacy Practice and Administrative Sciences, College of Pharmacy, and assistant director-Viral Hepatitis Programs, ECHO Institute, University of New Mexico Health Sciences Center, Albuquerque, New Mexico.

Reviewed by: Michelle T. Martin, Pharm.D., FCCP, BCPS, BCACP; Rasha Abdelsalam Elshenawy Sr, M.S., BCPS-AQ ID, CPHQ; Philip Chung, Pharm.D., M.S., BCPS; and Polina Plotkin, Pharm.D., BCACP

Target Audience and Learning Objectives

Target Audience

The target audience for this application-based activity are pharmacotherapy specialists and advanced-level clinical pharmacists caring for patients with hepatitis C infection.

Learning Objectives

  1. Design a pharmacotherapeutic treatment plan for the patient with chronic hepatitis C (HCV) infection.
  2. Given clinical patient and laboratory data, assess pharmacotherapy for a patient with chronic HCV infection.
  3. Assess and recommend a pharmacotherapeutic plan for special patient populations with chronic HCV infection.

Continuing Pharmacy Education and Recertification Instructions

Available CPE credits: Purchasers who purchase and successfully complete the required posttest for this PSAP in JACCP feature can earn 1.5 contact hours of CPE credit.

Hepatitis C Virus Infection
Universal Activity Number: 0217-0000-18-233-H01-P
1.5 CPE contact hours.
Application-Based Activity

Release date: October 5, 2018
BCPS posttest submission deadline: 11:59 p.m. (Central) on April 15, 2019.
ACPE posttest submission deadline: 11:59 p.m. (Central) on October 4, 2021.

TO EARN CPE CREDIT FROM THIS FEATURE
Posttest access: Purchase the required posttest (see below); then go to www.accp.com and sign in with your e-mail address and password. Technical support is available from 8 a.m. to 5 p.m. (Central) weekdays by calling (913) 492-3311. PSAP in JACCP features are listed under My Products on your My Account page.

Fees

Description Price Cart
Hepatitis C Virus Infection Posttest
Includes online ACPE CPE/Recertification Credit posttest.
Posttest submission deadline for BCPS recertification credit is April 15, 2019.
Posttest submission deadline for ACPE CPE credit is October 4, 2021.
$29.95

Faculty Information

This feature was developed from Factor Products, published in PSAP 2018 Book 2 (Hematology/Immunology/Oncology).

Author information: Cassie A. Barton, Pharm.D., BCPS, BCCCP is a trauma surgical critical care specialist in the Department of Pharmacy, Oregon Health & Science University, Portland, Oregon. Jesse Bierman, Pharm.D., BCCCP is a medical critical care specialist in the Department of Pharmacy Services, Oregon Health & Science University, Portland, Oregon.

Reviewed by: Reviewed by Sheh-Li Chen, Pharm.D., BCOP; Kimberli M. Burgner, Pharm.D., M.S., BCPS; and Elaine Law, Pharm.D., BCPS

Target Audience and Learning Objectives

Target audience for this application-based activity: pharmacotherapy specialists and advanced-level clinical pharmacists caring for patients receiving treatment with factor products.

Learning Objectives

  1. Distinguish between different clotting factor deficiencies and the available clotting factors.
  2. Devise a dosing and monitoring plan for acute bleeding in the patient with a clotting factor deficiency.
  3. Distinguish among reversal strategies for different anticoagulant agents.
  4. Delineate the role of individual reversal agents in coagulopathy normalization, together with the risk profile and monitoring values for each agent.

Disclosure of potential conflicts of interest: Nothing to disclose: Cassie A. Barton; Jesse Bierman; Kimberli M. Burgner; Sheh-Li Chen; and Elaine Law.

Continuing Pharmacy Education and Recertification Instructions

Available CPE credits: Anyone who purchases and successfully completes the required posttest for this feature can earn 1.5 contact hours of CPE credit.

Factor Products
Universal Activity Number: 0217-0000-19-078-H01-P
1.5 CPE contact hours.
Application-Based Activity

Release date: February 4, 2019
BCPS posttest submission deadline: 11:59 p.m. (Central) on August 5, 2019.
ACPE posttest submission deadline: 11:59 p.m. (Central) on February 5, 2022.

TO EARN CPE CREDIT FROM THIS FEATURE
Posttest access: Purchase the required posttest (see below); then go to www.accp.com and sign in with your e-mail address and password. Technical support is available from 8 a.m. to 5 p.m. (Central) weekdays by calling (913) 492-3311. PSAP in JACCP features are listed under My Products on your My Account page.

Fees

Description Price Cart
Factor Products Posttest
Includes online ACPE CPE/Recertification Credit posttest.
Posttest submission deadline for BCPS recertification credit is August 5, 2019.
Posttest submission deadline for ACPE CPE credit is February 5, 2022.
$29.95

Faculty Information

This feature was developed from Epilepsy, published in PSAP 2018 Book 3 (Neurology/Psychiatry).

Author information: Jeannine M. Conway, Pharm.D., BCPS is an associate professor and assistant dean of professional education at the University of Minnesota, College of Pharmacy, Minneapolis, Minnesota. Coauthor of the original chapter was Kimberly B. Tallian, Pharm.D., FCCP, BCPP, advanced practice pharmacist – neuropsychiatry at Scripps Mercy Hospital – San Diego; and adjunct professor of clinical sciences at Skaggs School of Pharmacy & Pharmaceutical Sciences, San Diego, California.

Reviewed by: Reviewed by Mikiko Y. Takeda, Pharm.D., MS, PhC; Jennifer Austin Szwak, Pharm.D., BCPS; and Janna Kittle, Pharm.D., BCPS, BCGP

Target Audience and Learning Objectives

Target audience for this application-based activity: Pharmacotherapy specialists and advanced-level clinical pharmacists caring for pediatric or adult patients with epilepsy.

Learning Objectives

  1. Apply considerations of quality of life when optimizing care for a patient with epilepsy.
  2. Design an appropriate antiepileptic drug (AED) regimen, including monitoring, for a patient with epilepsy.
  3. Evaluate an AED regimen on the basis of patient-specific considerations.
  4. Evaluate data on emerging treatments, sudden unexpected death in epilepsy, suicidality, and generic formulations.

Disclosure of potential conflicts of interest: Mikiko Y. Takeda: Consultancies (UCB); Honoraria (Roseman University). Jennifer Austin Szwak: nothing to disclose. Janna Kittle: Consultancies (Heron Therapeutics).

Continuing Pharmacy Education and Recertification Instructions

Available CPE credits: Anyone who purchases and successfully completes the required posttest for this feature can earn 1.5 contact hours of CPE credit.

Epilepsy
Universal Activity Number: 0217-0000-19-128-H01-P
1.5 CPE contact hours.
Application-Based Activity

Release date: June 5, 2019
BCPS posttest submission deadline: 11:59 p.m. (Central) on December 5, 2019.
ACPE posttest submission deadline: 11:59 p.m. (Central) on June 5, 2022.

TO EARN CPE CREDIT FROM THIS FEATURE
Posttest access: Purchase the required posttest (see below); then go to www.accp.com and sign in with your e-mail address and password. Technical support is available from 8 a.m. to 5 p.m. (Central) weekdays by calling (913) 492-3311. PSAP in JACCP features are listed under My Products on your My Account page.

Fees

Description Price Cart
Epilepsy Posttest
Includes online ACPE CPE/Recertification Credit posttest.
Posttest submission deadline for BCPS recertification credit is December 5, 2019.
Posttest submission deadline for ACPE CPE credit is June 5, 2022.
$29.95

Faculty Information

This feature was developed from the Complex Management of Atrial Fibrillation chapter published in PSAP 2019 Book 1 (Cardiology).

Author information: Bethany A. Kalich, Pharm.D., BCPS-AQ Cardiology, is an assistant professor at Feik School of Pharmacy, University of the Incarnate Word, San Antonio, Texas.

Reviewed by: Shannon W. Finks, Pharm.D., FCCP, BCPS; Melanie R. Madorsky, Pharm.D., BCPS, BCCP; and Maha O. Kebir, Pharm.D., BCPS

Target Audience and Learning Objectives

Target audience for this application-based activity: Pharmacotherapy specialists and advanced-level clinical pharmacists caring for patients with atrial fibrillation.

Learning Objectives

  1. Distinguish between appropriate oral anticoagulation (OAC) regimens for patients with comorbid valvular heart disease and atrial fibrillation (AF) versus patients with valvular AF.
  2. Design appropriate OAC regimens for patients with AF complicating acute coronary syndrome.
  3. Design an OAC regimen that minimizes bleeding risk in the perioperative setting.
  4. Justify the pharmacist’s role in the shared decision-making process for guideline-directed therapy and management principles.

Disclosure of potential conflicts of interest: Bethany Kalich: Consultancies (Sanofi/Regeneron), Stock Ownership (Amgen, Inc.), Other (founder of EmpowerRx Health Education Providers, LLC); Shannon W. Finks: nothing to disclose; Melanie R. Madorsky: nothing to disclose; and Maha O. Kebir: nothing to disclose

Continuing Pharmacy Education and Recertification Instructions

Available CPE credits: Anyone who purchases and successfully completes the required posttest for this feature can earn 1.5 contact hours of CPE credit.

Complex Management of Atrial Fibrillation
Universal Activity Number: 0217-0000-19-206-H01-P
1.5 CPE contact hours.
Application-Based Activity

Release date: December 6, 2019
ORIGINAL BCPS posttest submission deadline: 11:59 p.m. (Central) on June 6, 2020.
EXTENDED BCPS posttest submission deadline: 11:59 p.m. (Central) on August 1, 2020.
ACPE posttest submission deadline: 11:59 p.m. (Central) on December 8, 2022.

TO EARN CPE CREDIT FROM THIS FEATURE
Posttest access: Purchase the required posttest (see below); then go to www.accp.com and sign in with your e-mail address and password. Technical support is available from 8 a.m. to 5 p.m. (Central) weekdays by calling (913) 492-3311. PSAP in JACCP features are listed under My Products on your My Account page.

Fees

Description Price Cart
Complex Management of Atrial Fibrillation Posttest
Includes online ACPE CPE/Recertification Credit posttest.
ORIGINAL Posttest submission deadline for BCPS recertification credit was June 6, 2020.
EXTENDED Posttest submission deadline for BCPS recertification credit is August 1, 2020.
Posttest submission deadline for ACPE CPE credit is December 8, 2022.
$29.95

Faculty Information

PSAP in JACCP features are developed from activities presented as part of the Pharmacotherapy Self-Assessment Program (PSAP). This feature was developed from a recorded webcast appearing in PSAP 2019 Book 3 (Endocrinology and Nephrology).

Author information: John M. Moorman, Pharm.D., BCPS, is a Clinical Associate Professor of Pharmacy Practice at Northeast Ohio Medical University in Rootstown, Ohio.

Reviewed by: Reviewed by Kim L. Kelly, Pharm.D., FCCP, BCPS, CDTC; Michelle L. Rager, Pharm.D., BCPS, CDE; and Kathryn Corlett, Pharm.D., BCPS

Target Audience and Learning Objectives

Target audience for this application-based activity: Pharmacotherapy specialists and advanced-level clinical pharmacists caring for patients requiring monitoring and pharmacotherapy for diabetes mellitus.

Learning Objectives

Part I: Recorded Webcast: Continuous Glucose Monitoring Systems

  1. Apply recommendations from clinical practice guidelines with regard to continuous glucose monitoring (CGM) systems for patients with diabetes mellitus (DM).
  2. Distinguish between the various CGM systems.
  3. Evaluate available evidence regarding the use of CGM systems in patients with DM.
  4. Develop a therapy plan for patients with DM that incorporates CGM systems in conjunction with standard of care.

Part II: Recorded Webcast: Subcutaneous Insulin Infusion Devices

  1. Apply recommendations from clinical practice guidelines with respect to continuous subcutaneous insulin infusion (CSII) devices for patients with diabetes mellitus (DM).
  2. Distinguish between the various CSII devices.
  3. Evaluate available evidence regarding the use of CSII devices in patients with DM.
  4. Develop a therapy plan for patients with DM that incorporates CSII devices in conjunction with standard of care.

Disclosure of potential conflicts of interest: John M. Moorman: (Consultancies: Wolters Kluwer [Lexicomp]); Kim L. Kelly: (Consultancies: Abbott Diabetes Care; Johnson & Johnson Diabetes Institute; Becton Dickinson); Michelle L. Rager: nothing to disclose; and Kathryn Corlett: nothing to disclose

Continuing Pharmacy Education and Recertification Instructions

Available CPE credits: Anyone who purchases and successfully completes the required posttests for this feature can earn up to a total 3.0 contact hours of CPE credit.

Part I: Recorded Webcast: Continuous Glucose Monitoring Systems
Universal Activity Number: 0217-0000-20-119-H04-P
1.5 CPE contact hours.
Application-Based Activity

Part II: Recorded Webcast: Subcutaneous Insulin Infusion Devices
Universal Activity Number: 0217-0000-20-120-H04-P
1.5 CPE contact hours.
Application-Based Activity

Release date: June 5, 2020
BCPS posttest submission deadline: 11:59 p.m. (Central) on December 6, 2020.
ACPE posttest submission deadline: 11:59 p.m. (Central) on June 5, 2023.

TO EARN CPE CREDIT FROM THIS FEATURE
Posttest access: Purchase the required posttest (see below); then go to www.accp.com and sign in with your e-mail address and password. Technical support is available from 8 a.m. to 5 p.m. (Central) weekdays by calling (913) 492-3311. PSAP in JACCP features are listed under My Products on your My Account page.

Fees

Description Price Cart
Part I:  Recorded Webcast: Continuous Glucose Monitoring Systems
Part II: Recorded Webcast: Subcutaneous Insulin Infusion Devices

Includes online ACPE CPE/Recertification Credit posttests.
Posttest submission deadline for BCPS recertification credit is December 6, 2020.
Posttest submission deadline for ACPE CPE credit is June 5, 2023.
$29.95

 

Continuing Pharmacy Education (CPE) Credit

ACPE

The American College of Clinical Pharmacy is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.

 

ACPE CPE Credit: To receive ACPE CPE credit, the required posttest must be submitted within 3 years after the book’s release. Only completed posttests are eligible for credit; no partial or incomplete posttests will be processed. Posttests may not be submitted more than one time.

Any posttest submitted before the ACPE deadline that scores 50% or greater will be awarded the appropriate CPE. These credits will be assigned as of the date of posttest submission and reported within 48 hours. For statements of CPE credit, visit www.mycpemonitor.net.

Posttest answers: The explained answers – with rationale and supporting references – will be posted 1 week after the BCPS posttest deadline and will be available to anyone who has submitted a posttest.

BCPS Credit

BCPS Recertification Credit: To receive BCPS recertification CPE credit, the required posttest must be submitted within the 6-month period after the feature’s release. Only completed posttests are eligible for credit; no partial or incomplete posttests will be processed. Posttests may not be submitted more than one time.

The passing point to earn BCPS recertification credit is based on an expert analysis of the assessment items in each posttest module. Any posttest submitted before the BCPS posttest deadline that meets this passing point will earn BCPS recertification credits. These credits will be assigned as of the date of posttest submission and reported within 48 hours to BPS. For statements of recertification credit, visit www.bpsweb.org.

Technical Requirements

Requires an Internet browser and Adobe Reader.

Financial Support

The American College of Clinical Pharmacy does not solicit or accept external commercial/financial support for its continuing pharmacy education activities. No commercial/financial support has been solicited or accepted for this activity.